Suppression of KIF14 expression inhibits hepatocellular carcinoma progression and predicts favorable outcome

Cancer Science

Volumn 104, Issue 5, 2013, Pages 552-557

  Yang, Tao ^a   Zhang, Xian Bo ^a   Zheng, Zhi Min ^a  

^a FIRST HOSPITAL OF SHIJIAZHUANG   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; KIF14 GENE; LIVER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ONCOGENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; KINESIN; LIVER NEOPLASMS; MICE; MICE, NUDE; MIDDLE AGED; ONCOGENE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; TRANSPLANTATION, HETEROLOGOUS;

EID: 84876419002     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12128     Document Type: Article

References (23)

1. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-46.
2. Miki H, Okada Y, Hirokawa N. Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol 2005; 15: 467-76.
3. Zhu C, Zhao J, Bibikova M et al. Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. Mol Biol Cell 2005; 16: 3187-99.
4. Huszar D, Theoclitou ME, Skolnik J, Herbst R. Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev 2009; 28: 197-208.
5. Yu Y, Feng YM. The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy. Cancer 2010; 116: 5150-60.
6. Nomura N, Nagase T, Miyajima N et al. Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1 (supplement). DNA Res 1994; 1: 251-62.
7. Theriault BL, Pajovic S, Bernardini MQ, Shaw PA, Gallie BL. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer. Int J Cancer 2012; 130: 1844-54.
8. Gruneberg U, Neef R, Li X et al. KIF14 and citron kinase act together to promote efficient cytokinesis. J Cell Biol 2006; 172: 363-72.
9. Carleton M, Mao M, Biery M et al. RNA interference-mediated silencing of mitotic kinesin KIF14 disrupts cell cycle progression and induces cytokinesis failure. Mol Cell Biol 2006; 26: 3853-63.
10. Corson TW, Huang A, Tsao MS, Gallie BL. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 2005; 24: 4741-53.
11. Madhavan J, Coral K, Mallikarjuna K et al. High expression of KIF14 in retinoblastoma: association with older age at diagnosis. Invest Ophthalmol Vis Sci 2007; 48: 4901-6.
12. Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, Gallie BL. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clin Cancer Res 2007; 13: 3229-34.
13. Madhavan J, Mitra M, Mallikarjuna K et al. KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association. Mol Vis 2009; 15: 235-40.
14. Corson TW, Gallie BL. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer. Int J Cancer 2006; 119: 1088-94.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
16. Reis-Filho JS, Drury S, Lambros MB et al. ESR1 gene amplification in breast cancer: a common phenomenon? Nat Genet 2008; 40: 809-10; author reply 810-812.
17. Reginato MJ, Mills KR, Paulus JK et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 2003; 5: 733-40.
18. Darzynkiewicz Z, Bedner E, Smolewski P. Flow cytometry in analysis of cell cycle and apoptosis. Semin Hematol 2001; 38: 179-93.
19. Kim TM, Yim SH, Shin SH et al. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer 2008; 123: 2808-15.
20. Huang Q, Lin B, Liu H et al. RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PLoS ONE 2011; 6: e26168.
21. Wang Q, Wang L, Li D et al. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients. Cancer Epidemiol 2013; 37: 79-84.
22. Blackhall FH, Wigle DA, Jurisica I et al. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study. Lung Cancer 2004; 46: 197-204.
23. Zhang C, Zhu C, Chen H et al. Kif18A is involved in human breast carcinogenesis. Carcinogenesis 2010; 31: 1676-84.